Rockefeller Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.6M Sell
131,535
-11,796
-8% -$1.49M 0.04% 442
2025
Q1
$18.3M Buy
143,331
+1,480
+1% +$189K 0.05% 389
2024
Q4
$18.8M Sell
141,851
-4,943
-3% -$654K 0.05% 362
2024
Q3
$21.4M Sell
146,794
-8,860
-6% -$1.29M 0.06% 317
2024
Q2
$21.4M Buy
155,654
+36,491
+31% +$5.01M 0.06% 298
2024
Q1
$16.4M Buy
119,163
+5,800
+5% +$796K 0.05% 377
2023
Q4
$15.4M Sell
113,363
-463
-0.4% -$62.9K 0.05% 352
2023
Q3
$13.9M Buy
113,826
+2,470
+2% +$302K 0.05% 344
2023
Q2
$14.1M Sell
111,356
-95,403
-46% -$12.1M 0.05% 355
2023
Q1
$26.7M Buy
206,759
+109,917
+114% +$14.2M 0.11% 202
2022
Q4
$12.7M Buy
96,842
+13,574
+16% +$1.78M 0.06% 319
2022
Q3
$9.74M Sell
83,268
-6,363
-7% -$744K 0.05% 363
2022
Q2
$10.5M Sell
89,631
-3,702
-4% -$435K 0.06% 332
2022
Q1
$12.2M Sell
93,333
-39,201
-30% -$5.11M 0.06% 321
2021
Q4
$20.2M Buy
132,534
+25,454
+24% +$3.88M 0.09% 220
2021
Q3
$17.3M Buy
107,080
+4,484
+4% +$725K 0.09% 231
2021
Q2
$16.8M Buy
102,596
+23,548
+30% +$3.85M 0.09% 232
2021
Q1
$11.9M Buy
79,048
+3,397
+4% +$511K 0.08% 238
2020
Q4
$11.5M Buy
75,651
+23,888
+46% +$3.62M 0.09% 215
2020
Q3
$7.01M Buy
51,763
+14,119
+38% +$1.91M 0.07% 230
2020
Q2
$5.15M Buy
37,644
+13,428
+55% +$1.84M 0.05% 241
2020
Q1
$2.61M Buy
24,216
+2,994
+14% +$323K 0.03% 301
2019
Q4
$2.56M Buy
21,222
+6,768
+47% +$815K 0.03% 304
2019
Q3
$1.44M Buy
14,454
+3,317
+30% +$330K 0.02% 336
2019
Q2
$1.22M Sell
11,137
-1,472
-12% -$161K 0.02% 320
2019
Q1
$1.41M Buy
12,609
+11,646
+1,209% +$1.3M 0.02% 319
2018
Q4
$93K Buy
+963
New +$93K ﹤0.01% 462
2018
Q2
Sell
-7,500
Closed -$801K 778
2018
Q1
$801K Buy
+7,500
New +$801K 0.01% 235